Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | NHS England |
| Main Category: | Services |
| Procurement Method: | Call-off from a framework agreement |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | £949,936.8 |
| Release Date: | 22 April 2026 |
| Application Deadline: | 31 March 2025 |
| Contract Start Date: | 14 October 2025 |
View Original Notice
Access the full notice on the official portal
🤝 Need a consortium or subcontracting partner?
SMEs & Primes team up to win opportunities like this. Find partners on the board.
Awarded to
| Award value: | £949,936.8 |
| Award decision date: | 21 April 2026 |
| Award status: | Active |
his request is for re-procurement same scope for 18 months, via a compliant Direct Ward National framework for the EONIS Q Assay methodology, as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot for Severe Combined Immuno-Deficiency (SCID) in-service evaluation (ISE) in 4 Screening laboratories.
Published contracts in the last 12 months
2,046
total contracts
£179666.3m
total value
£251,986,446
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
31 March 2025
Closed
Estimated Value
£949,936.8
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Contract End Date: |
| 31 March 2026 |
| Contract Duration: | 6 months |
| Procurement ID (OCID): | ocds-b5fd17-926f56f6-d6e9-4264-afad-0092df1cecfa |
| Notice Reference: | 8d0fb9d2-b9be-4e84-8f08-cdc60061b058-894110 |